About
Julie Yoo is a general partner on the Bio + Health team, where she leads investments into companies that are transforming how we access, pay for, and experience healthcare. Her portfolio includes AKASA, Alchemy, Ambience, Aradigm, Counsel, Fortuna, Hippocratic AI, Leona, Sprinter Health, Thatch Health, and Turquoise Health.
Prior to joining Andreessen Horowitz, Julie was Co-Founder and Chief Product Officer of Kyruus, a VC-backed healthtech company where she helped build and scale the business from 0 to 20M patients and over 225,000 healthcare providers across the US using their platform (acquired by RevSpring). Before that, Julie was VP of Product at Generation Health (acquired by CVS Health) and a Product Manager at Knome. Julie’s tech career began as an early member of the software engineering and sales engineering team at Endeca Technologies, which was acquired by Oracle.
Julie studied computer science and pre-medicine as an undergrad at MIT and obtained an MS in genomics from Harvard-MIT HST and an MBA from MIT Sloan. Julie is a Young Global Leader with the World Economic Forum and has been recognized through numerous awards and honors from Midas Brink List, Becker’s Hospital Review, Modern Healthcare, Health Data Management, MedTech Boston, and Rock Health.
Latest Content by Julie
From Chaos to Clarity in Data with Malinka Walaliyadde
The Paradox of U.S. Healthcare with Marc Andreessen
Select Investments
Any investments or portfolio companies mentioned, referred to, or described on this page are not representative of all investments. A list of investments made by funds managed by a16z is available here: https://a16z.com/investment-list/.
Julie on X
Join the conversationWant More Bio+Health?
Insights, analysis, and additional reading on bio and health, and how both are shaping our future.
Want More Bio+Health?
Insights, analysis, and additional reading on bio and health, and how both are shaping our future.